Prime Medicine, Inc. (PRME) — DEF 14A Filings
All DEF 14A filings from Prime Medicine, Inc.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
Prime Medicine Seeks Shareholder Nod for Stock Option Repricing
— Jul 14, 2025 Risk: medium
Prime Medicine, Inc. (PRME) has filed a DEF 14A proxy statement for a Special Meeting of Stockholders on August 1, 2025, primarily to seek approval for the repr -
Prime Medicine Files 2024 Proxy Statement
— Apr 22, 2025 Risk: low
Prime Medicine, Inc. filed its definitive proxy statement (DEF 14A) on April 22, 2025, for its fiscal year ending December 31, 2024. The filing, originating fro -
Prime Medicine, Inc. Announces 2024 Annual Meeting of Stockholders on June 12, 2024
— Apr 29, 2024 Risk: low
Prime Medicine, Inc. (PRME) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. The 2024 Annual Meeting of Stockholders for Prime Medicine, Inc. w
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX